SCIENTIFIC BACKGROUND

ANOS1CHD7DUSP6FEZF1FGF17FGF8FGFR1FLRT3FSHBGNRH1GNRHRHS6ST1IL17RDKISS1KISS1RLHBNSMFPROK2PROKR2SEMA3ASOX10SPRY4TAC3TACR3WDR11

Kallmann syndrome is characterized by two main symptoms: hypogonadotropic hypogonadism (HH) and absent or diminished sense of smell (anosmia). The incidence is reported to be 1:8,000 (males) and 1:40,000 (females). There are three modes of inheritance:

 

  • an X-linked recessive form with pathogenic variants or deletions in the ANOS1 gene (KAL1; seen in approximately 8% of patients),
  • an autosomal dominant form with variants in the FGFR1 gene (fibroblast growth factor receptor 1 gene, KAL2; seen in approximately 10% of patients), and
  • an autosomal recessive form with variants in the PROKR2 (prokineticin receptor 2 gene, KAL3) and PROK2 (prokineticin 2 gene, KAL4) genes (seen in approximately 9% of patients).

 

Variants in CHD7 (chromodomain helicase DNA-binding protein-7 gene, KAL5; 6-8% of patients) have also been described for Kallmann syndrome or idiopathic hypogonadotropic hypogonadism (IHH) with normosmia as clinically milder forms of CHARGE syndrome. Another autosomal dominant form is caused by variants in FGF8 (fibroblast growth factor-8 gene, KAL6; approximately 2% of patients). Diagnostic testing also includes examination of the genes DUSP6, FEZF1, FGF17, FLRT3, FSHB, GNRH1, GNRHR, HS6ST1, IL17RD, KISS1, KISS1R, LHB, NSMF, SEMA3A, SOX10, SPRY4, TAC3, TACR3, and WDR11, in which causative variants for HH have been identified as well. Furthermore, a digenic cause for HH has been reported several times, where the combination of one variant in each of two different genes (e.g. in FGFR1 and FGF8 or in FGFR1 and GNRHR) leads to the development of the disease. Through the examination of these 25 genes, diagnostic sensitivity of approximately 50% is achieved.

 

References

Stamou et Georgopoulos 2018, Metabol 86:124 / Marcos et al. 2014, J Clin Endocrinol Metab 99:E2138 / Miraoui et al. 2013, Am J Hum Genet 92:725 / Dode et Hardelin 2009, Eur J Hum Genet17:139 / Pitteloud et al 2007, J Clin Invest 117:457

GENES

ANOS1CHD7DUSP6FEZF1FGF17FGF8FGFR1FLRT3FSHBGNRH1GNRHRHS6ST1IL17RDKISS1KISS1RLHBNSMFPROK2PROKR2SEMA3ASOX10SPRY4TAC3TACR3WDR11

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more